Skin antiseptics used prior to intravascular catheter insertion

Br J Nurs. 2007 Mar;16(5):278-80. doi: 10.12968/bjon.2007.16.5.22997.

Abstract

The recent epic2 publication (Pratt et al, 2007) provides evidence-based guidelines for the prevention of healthcare-associated infections. One of the new recommendations related to the prevention of central venous catheter (CVC) associated infection states that 2% chlorhexidine gluconate (CHG) in 70% isopropyl alcohol (IPA) should be used for cutaneous antisepsis prior to device insertion. This article reviews cutaneous antisepsis prior to intravascular catheter placement.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • 2-Propanol / therapeutic use
  • Anti-Infective Agents, Local / therapeutic use*
  • Catheterization, Central Venous* / adverse effects
  • Chlorhexidine / analogs & derivatives
  • Chlorhexidine / therapeutic use
  • Clinical Trials as Topic
  • Cross Infection / epidemiology
  • Cross Infection / etiology
  • Cross Infection / prevention & control
  • England / epidemiology
  • Evidence-Based Medicine
  • Humans
  • Infection Control / methods*
  • Infection Control / standards
  • Povidone-Iodine / therapeutic use
  • Practice Guidelines as Topic
  • Sepsis / epidemiology
  • Sepsis / etiology
  • Sepsis / prevention & control
  • Skin Care / methods*
  • Skin Care / standards

Substances

  • Anti-Infective Agents, Local
  • Povidone-Iodine
  • chlorhexidine gluconate
  • 2-Propanol
  • Chlorhexidine